NP34925a Hepatitis B immunoglobulin intramuscular use (IM)

Concepts

• edinburgh
• pharmaceutical products
• hepatitis b immunoglobulin
• im
• hepatitis
• np34925a hepatitis b immunoglobulin
• use
• np34925a
• intramuscular
• immunoglobulin

Location

The Scottish National Blood Transfusion Service, Edinburgh (SNBTS). OR Upon request: designated delivery points throughout Scotland for use by Participating Authorities.

Description

Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.

Total Quantity or Scope

The Framework Agreement is for the supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.

Award Detail

CPV Codes

• 33600000 - Pharmaceutical products

Legal Justification

Although Hepatitis B immunoglobulin intramuscular use (IM) has lost patent protection there is no known generic competition in the UK marketplace due to the difficulties in replicating the manufacturing process, in line with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value of the Framework Agreement referred to in Section V.2.4 covers the twenty-four (24) month contract duration and the twenty-four (24) month extension period of the Framework Agreement. (SC Ref:796275)